Species specificity of type III interferon activity and development of a sensitive luciferase-based bioassay for quantitation of mouse interferon-λ
- Author
- Sophie Jacobs, Fanny Wavreil, Bert Schepens (UGent) , Hans Henrik Gad, Rune Hartmann, Joana Rocha-Pereira, Johan Neyts, Xavier Saelens (UGent) and Thomas Michiels
- Organization
- Abstract
- The type III interferon (IFN-lambda) family includes 4 IFN-lambda subtypes in man. In the mouse, only the genes coding for IFN-lambda 2 and -lambda 3 are present. Unlike mouse and human type I IFNs (IFN-alpha/beta), which exhibit strong species specificity, type III IFNs were reported to act in a cross-specific manner. We reexamined the cross-specificity and observed that mouse and human IFN-lambda exhibit some species specificity, although much less than type I IFNs. Mouse IFN-lambda 3 displayed clear species specificity, being 25-fold less active in human cells than the closely related mouse IFN-lambda 2. This specificity likely depends on amino acids in alpha helices A and F that diverged from other IFN-lambda sequences. Human IFN-lambda 4, in contrast, retained high activity in mouse cells. We next developed a firefly luciferase-based reporter cell line, named Fawa-lambda-luc, to detect IFN-lambda in biological fluids with high specificity and sensitivity. Fawa-lambda-luc cells, derived from mouse epithelial cells that are responsive to IFN-lambda, were made nonresponsive to type I IFNs by inactivation of the Ifnar2 gene and strongly responsive to IFN-lambda by overexpression of the mouse IFNLR1. This bioassay was as sensitive as a commercially available enzyme-linked immunosorbent assay in detecting mouse IFN-lambda in cell culture supernatant, as well as in serum and bronchoalveolar lavage samples of virus-infected mice. The assay also enabled the sensitive detection of human IFN-lambda activity, including that of the divergent IFN-lambda 4 with a bias, however, due to variable activity of IFN-lambda subtypes.
- Keywords
- species-specific activity, cross-species activity, IFN-lambda receptor, IFN-lambda, type I IFN, antiviral, cytokine, respiratory syncytial virus, IFN-LAMBDA, FUNCTIONAL-ANALYSIS, ANTIVIRAL ACTIVITY, RECEPTOR, VIRUS, INFLAMMATION, PROTECTION, IL-29
Downloads
-
jir.2018.0066.pdf
- full text
- |
- open access
- |
- |
- 757.81 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8583715
- MLA
- Jacobs, Sophie, et al. “Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ.” JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, vol. 38, no. 11, 2018, pp. 469–79, doi:10.1089/jir.2018.0066.
- APA
- Jacobs, S., Wavreil, F., Schepens, B., Gad, H. H., Hartmann, R., Rocha-Pereira, J., … Michiels, T. (2018). Species specificity of type III interferon activity and development of a sensitive luciferase-based bioassay for quantitation of mouse interferon-λ. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 38(11), 469–479. https://doi.org/10.1089/jir.2018.0066
- Chicago author-date
- Jacobs, Sophie, Fanny Wavreil, Bert Schepens, Hans Henrik Gad, Rune Hartmann, Joana Rocha-Pereira, Johan Neyts, Xavier Saelens, and Thomas Michiels. 2018. “Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ.” JOURNAL OF INTERFERON AND CYTOKINE RESEARCH 38 (11): 469–79. https://doi.org/10.1089/jir.2018.0066.
- Chicago author-date (all authors)
- Jacobs, Sophie, Fanny Wavreil, Bert Schepens, Hans Henrik Gad, Rune Hartmann, Joana Rocha-Pereira, Johan Neyts, Xavier Saelens, and Thomas Michiels. 2018. “Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ.” JOURNAL OF INTERFERON AND CYTOKINE RESEARCH 38 (11): 469–479. doi:10.1089/jir.2018.0066.
- Vancouver
- 1.Jacobs S, Wavreil F, Schepens B, Gad HH, Hartmann R, Rocha-Pereira J, et al. Species specificity of type III interferon activity and development of a sensitive luciferase-based bioassay for quantitation of mouse interferon-λ. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH. 2018;38(11):469–79.
- IEEE
- [1]S. Jacobs et al., “Species specificity of type III interferon activity and development of a sensitive luciferase-based bioassay for quantitation of mouse interferon-λ,” JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, vol. 38, no. 11, pp. 469–479, 2018.
@article{8583715,
abstract = {{The type III interferon (IFN-lambda) family includes 4 IFN-lambda subtypes in man. In the mouse, only the genes coding for IFN-lambda 2 and -lambda 3 are present. Unlike mouse and human type I IFNs (IFN-alpha/beta), which exhibit strong species specificity, type III IFNs were reported to act in a cross-specific manner. We reexamined the cross-specificity and observed that mouse and human IFN-lambda exhibit some species specificity, although much less than type I IFNs. Mouse IFN-lambda 3 displayed clear species specificity, being 25-fold less active in human cells than the closely related mouse IFN-lambda 2. This specificity likely depends on amino acids in alpha helices A and F that diverged from other IFN-lambda sequences. Human IFN-lambda 4, in contrast, retained high activity in mouse cells. We next developed a firefly luciferase-based reporter cell line, named Fawa-lambda-luc, to detect IFN-lambda in biological fluids with high specificity and sensitivity. Fawa-lambda-luc cells, derived from mouse epithelial cells that are responsive to IFN-lambda, were made nonresponsive to type I IFNs by inactivation of the Ifnar2 gene and strongly responsive to IFN-lambda by overexpression of the mouse IFNLR1. This bioassay was as sensitive as a commercially available enzyme-linked immunosorbent assay in detecting mouse IFN-lambda in cell culture supernatant, as well as in serum and bronchoalveolar lavage samples of virus-infected mice. The assay also enabled the sensitive detection of human IFN-lambda activity, including that of the divergent IFN-lambda 4 with a bias, however, due to variable activity of IFN-lambda subtypes.}},
author = {{Jacobs, Sophie and Wavreil, Fanny and Schepens, Bert and Gad, Hans Henrik and Hartmann, Rune and Rocha-Pereira, Joana and Neyts, Johan and Saelens, Xavier and Michiels, Thomas}},
issn = {{1079-9907}},
journal = {{JOURNAL OF INTERFERON AND CYTOKINE RESEARCH}},
keywords = {{species-specific activity,cross-species activity,IFN-lambda receptor,IFN-lambda,type I IFN,antiviral,cytokine,respiratory syncytial virus,IFN-LAMBDA,FUNCTIONAL-ANALYSIS,ANTIVIRAL ACTIVITY,RECEPTOR,VIRUS,INFLAMMATION,PROTECTION,IL-29}},
language = {{eng}},
number = {{11}},
pages = {{469--479}},
title = {{Species specificity of type III interferon activity and development of a sensitive luciferase-based bioassay for quantitation of mouse interferon-λ}},
url = {{http://doi.org/10.1089/jir.2018.0066}},
volume = {{38}},
year = {{2018}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: